30635783|t|Combination of Insulin with a GLP1 Agonist Is Associated with Better Memory and Normal Expression of Insulin Receptor Pathway Genes in a Mouse Model of Alzheimer's Disease.
30635783|a|Disruption of brain insulin signaling may explain the higher Alzheimer's disease (AD) risk among type 2 diabetic (T2D) patients. There is evidence from in vitro and human postmortem studies that combination of insulin with hypoglycemic medications is neuroprotective and associated with less amyloid aggregation. We examined the effect of 8-month intranasal administration of insulin, exenatide (a GLP-1 agonist), combination therapy (insulin + exenatide) or saline, in wild-type (WT) and an AD-like mouse model (Tg2576). Mice were assessed for learning, gene expression of key mediators and effectors of the insulin receptor signaling pathway (IRSP-IRS1, AKT1, CTNNB1, INSR, IRS2, GSK3B, IGF1R, AKT3), and brain Amyloid Beta (Abeta) levels. In Tg2576 mice, combination therapy reduced expression of IRSP genes which was accompanied by better learning. Cortical Abeta levels were decreased by 15-30% in all groups compared to saline but this difference did not reach statistical significance. WT mice groups, with or without treatment, did not differ in any comparison. Disentangling the mechanisms underlying the potential beneficial effects of combination therapy on the IR pathway and AD-like behavior is warranted.
30635783	15	22	Insulin	Gene	3630
30635783	30	34	GLP1	Gene	14526
30635783	101	117	Insulin Receptor	Gene	16337
30635783	137	142	Mouse	Species	10090
30635783	152	171	Alzheimer's Disease	Disease	MESH:D000544
30635783	193	200	insulin	Gene	3630
30635783	234	253	Alzheimer's disease	Disease	MESH:D000544
30635783	255	257	AD	Disease	MESH:D000544
30635783	270	285	type 2 diabetic	Disease	MESH:D003924
30635783	287	290	T2D	Disease	MESH:D003924
30635783	292	300	patients	Species	9606
30635783	338	343	human	Species	9606
30635783	383	390	insulin	Gene	3630
30635783	396	420	hypoglycemic medications	Chemical	-
30635783	465	484	amyloid aggregation	Disease	MESH:C000718787
30635783	549	556	insulin	Gene	3630
30635783	558	567	exenatide	Chemical	MESH:D000077270
30635783	571	576	GLP-1	Gene	14526
30635783	608	615	insulin	Gene	3630
30635783	618	627	exenatide	Chemical	MESH:D000077270
30635783	665	667	AD	Disease	MESH:D000544
30635783	673	678	mouse	Species	10090
30635783	686	692	Tg2576	CellLine	CVCL:S723
30635783	695	699	Mice	Species	10090
30635783	782	798	insulin receptor	Gene	16337
30635783	823	827	IRS1	Gene	16367
30635783	829	833	AKT1	Gene	11651
30635783	835	841	CTNNB1	Gene	12387
30635783	843	847	INSR	Gene	16337
30635783	849	853	IRS2	Gene	384783
30635783	855	860	GSK3B	Gene	56637
30635783	862	867	IGF1R	Gene	16001
30635783	869	873	AKT3	Gene	23797
30635783	900	905	Abeta	Gene	11820
30635783	918	924	Tg2576	CellLine	CVCL:S723
30635783	925	929	mice	Species	10090
30635783	1035	1040	Abeta	Gene	11820
30635783	1169	1173	mice	Species	10090
30635783	1346	1348	IR	Disease	MESH:C537629
30635783	1361	1363	AD	Disease	MESH:D000544
30635783	Association	MESH:D003924	3630
30635783	Association	MESH:C537629	16337
30635783	Negative_Correlation	MESH:C000718787	3630
30635783	Association	16337	3630
30635783	Association	MESH:D000544	3630
30635783	Positive_Correlation	MESH:D000077270	14526
30635783	Association	14526	16337
30635783	Association	MESH:D000544	16337

